Ikena Oncology (IKNA) News Today $1.35 -0.02 (-1.46%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$1.36 +0.01 (+0.74%) As of 06/13/2025 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IKNA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Ikena Oncology Reports Q1 Loss Amid Merger PlansMay 27, 2025 | tipranks.comIkena Oncology (NASDAQ:IKNA) Releases Earnings Results, Beats Expectations By $0.03 EPSIkena Oncology (NASDAQ:IKNA - Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.18) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.03.May 14, 2025 | marketbeat.comBrokers Set Expectations for Ikena Oncology Q1 EarningsIkena Oncology, Inc. (NASDAQ:IKNA - Free Report) - Analysts at William Blair issued their Q1 2026 earnings per share estimates for Ikena Oncology in a research report issued to clients and investors on Thursday, May 8th. William Blair analyst M. Phipps forecasts that the company will post earningMay 13, 2025 | marketbeat.comIkena Oncology (IKNA) Expected to Announce Earnings on MondayIkena Oncology (NASDAQ:IKNA) will be releasing its Q1 2025 earnings before the market opens on Monday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-12-ikena-oncology-inc-stock/)May 7, 2025 | marketbeat.comBVF Inc. IL Sells 762,600 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA)BVF Inc. IL lowered its position in Ikena Oncology, Inc. (NASDAQ:IKNA - Free Report) by 16.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,006,564 shares of the company's stock afterMay 6, 2025 | marketbeat.comIkena Oncology, Inc. (NASDAQ:IKNA) Short Interest UpdateIkena Oncology, Inc. (NASDAQ:IKNA - Get Free Report) was the recipient of a large drop in short interest during the month of March. As of March 31st, there was short interest totalling 113,900 shares, a drop of 24.9% from the March 15th total of 151,700 shares. Based on an average trading volume of 127,100 shares, the short-interest ratio is presently 0.9 days. Currently, 0.8% of the company's shares are short sold.April 21, 2025 | marketbeat.com2,008,338 Shares in Ikena Oncology, Inc. (NASDAQ:IKNA) Purchased by Gilead Sciences Inc.Gilead Sciences Inc. acquired a new position in shares of Ikena Oncology, Inc. (NASDAQ:IKNA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 2,008,338 shares of the company's stock, valuApril 20, 2025 | marketbeat.comIkena Oncology, Inc. (NASDAQ:IKNA) Stake Boosted by BML Capital Management LLCBML Capital Management LLC boosted its stake in Ikena Oncology, Inc. (NASDAQ:IKNA - Free Report) by 395.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,585,866 shares of the company's stock after purchasing an addMarch 8, 2025 | marketbeat.comIkena Oncology (NASDAQ:IKNA) Releases Earnings Results, Beats Estimates By $0.05 EPSIkena Oncology (NASDAQ:IKNA - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.18) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.05.March 7, 2025 | marketbeat.comIkena Oncology: Investor Caution as Dividend Payments Remain UnlikelyMarch 7, 2025 | tipranks.comIkena Oncology, Inc. (NASDAQ:IKNA) Short Interest Up 34.1% in FebruaryIkena Oncology, Inc. (NASDAQ:IKNA - Get Free Report) was the target of a significant increase in short interest during the month of February. As of February 15th, there was short interest totalling 154,100 shares, an increase of 34.1% from the January 31st total of 114,900 shares. Based on an average trading volume of 226,700 shares, the days-to-cover ratio is currently 0.7 days. Currently, 1.1% of the shares of the stock are sold short.March 4, 2025 | marketbeat.comIkena Oncology (IKNA) to Release Earnings on TuesdayIkena Oncology (NASDAQ:IKNA) will be releasing earnings before the market opens on Tuesday, March 11, Financial Modeling Prep reports.March 4, 2025 | marketbeat.comIkena Oncology, Inc. (NASDAQ:IKNA) Short Interest Down 11.8% in JanuaryIkena Oncology, Inc. (NASDAQ:IKNA - Get Free Report) saw a large drop in short interest during the month of January. As of January 31st, there was short interest totalling 114,900 shares, a drop of 11.8% from the January 15th total of 130,200 shares. Approximately 0.6% of the shares of the company are short sold. Based on an average daily volume of 226,200 shares, the short-interest ratio is currently 0.5 days.February 19, 2025 | marketbeat.comDiscovering February 2025's Promising Penny Stocks On US ExchangesFebruary 14, 2025 | finance.yahoo.comPeapod Lane Capital LLC Makes New $833,000 Investment in Ikena Oncology, Inc. (NASDAQ:IKNA)Peapod Lane Capital LLC acquired a new stake in Ikena Oncology, Inc. (NASDAQ:IKNA - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 507,868 shares of the company's stock, valued at approximatFebruary 13, 2025 | marketbeat.comIkena Oncology (NASDAQ:IKNA) Trading Down 0.7% - Here's WhyIkena Oncology (NASDAQ:IKNA) Stock Price Down 0.7% - Here's What HappenedFebruary 7, 2025 | marketbeat.comWilliam Blair Reaffirms Their Buy Rating on Ikena Oncology (IKNA)December 29, 2024 | markets.businessinsider.comiKena Oncology, Inmagene enter definitive merger agreement, private placementDecember 24, 2024 | markets.businessinsider.comIkena Oncology's (IKNA) "Neutral" Rating Reaffirmed at WedbushWedbush reaffirmed a "neutral" rating and issued a $2.00 target price on shares of Ikena Oncology in a report on Monday.December 23, 2024 | marketbeat.comIkena Oncology Shares Rise After Merger Announcement With Inmagene BiopharmaceuticalsDecember 23, 2024 | marketwatch.comIkena Oncology, Inmagene Biopharmaceuticals to MergeDecember 23, 2024 | marketwatch.comIkena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private PlacementDecember 23, 2024 | globenewswire.comIkena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private PlacementDecember 23, 2024 | globenewswire.comHC Wainwright Forecasts Higher Earnings for Ikena OncologyIkena Oncology, Inc. (NASDAQ:IKNA - Free Report) - Investment analysts at HC Wainwright upped their FY2024 earnings per share (EPS) estimates for shares of Ikena Oncology in a research note issued on Monday, November 11th. HC Wainwright analyst A. Maldonado now forecasts that the company will posNovember 14, 2024 | marketbeat.comBuy Rating for Ikena Oncology Driven by Promising IK-595 DevelopmentsNovember 11, 2024 | markets.businessinsider.comHC Wainwright Reiterates "Buy" Rating for Ikena Oncology (NASDAQ:IKNA)HC Wainwright reaffirmed a "buy" rating and issued a $4.00 price objective on shares of Ikena Oncology in a research report on Monday.November 11, 2024 | marketbeat.comIkena Oncology Reports Strategic Realignment and Financial PerformanceNovember 8, 2024 | markets.businessinsider.comIkena Oncology Reports Third Quarter 2024 Financial ResultsNovember 7, 2024 | globenewswire.comRenaissance Technologies LLC Sells 300,200 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA)Renaissance Technologies LLC cut its stake in Ikena Oncology, Inc. (NASDAQ:IKNA - Free Report) by 38.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 476,400 shares of the company's stock after sellinOctober 8, 2024 | marketbeat.comIkena Oncology (NASDAQ:IKNA) Stock Quotes, Forecast and News SummaryOctober 7, 2024 | benzinga.comIkena Oncology, Inc. (NASDAQ:IKNA) Sees Large Drop in Short InterestIkena Oncology, Inc. (NASDAQ:IKNA - Get Free Report) saw a significant decrease in short interest during the month of August. As of August 15th, there was short interest totalling 313,600 shares, a decrease of 10.8% from the July 31st total of 351,500 shares. Based on an average daily volume of 279,400 shares, the short-interest ratio is currently 1.1 days. Approximately 1.1% of the company's stock are sold short.September 1, 2024 | marketbeat.comIkena Oncology, Inc. (NASDAQ:IKNA) Sees Significant Decrease in Short InterestIkena Oncology, Inc. (NASDAQ:IKNA - Get Free Report) saw a significant decrease in short interest in July. As of July 31st, there was short interest totalling 351,500 shares, a decrease of 10.7% from the July 15th total of 393,700 shares. Currently, 1.5% of the shares of the company are sold short. Based on an average daily volume of 295,600 shares, the days-to-cover ratio is presently 1.2 days.August 18, 2024 | marketbeat.comIkena Oncology, Inc. (NASDAQ:IKNA) Expected to Post Q3 2024 Earnings of ($0.26) Per ShareIkena Oncology, Inc. (NASDAQ:IKNA - Free Report) - Stock analysts at HC Wainwright lifted their Q3 2024 earnings estimates for shares of Ikena Oncology in a research report issued to clients and investors on Monday, August 12th. HC Wainwright analyst A. Maldonado now expects that the company willAugust 15, 2024 | marketbeat.comIkena Oncology, Inc.: Ikena Oncology Reports Second Quarter 2024 Financial ResultsAugust 10, 2024 | finanznachrichten.deIkena Oncology Reports Second Quarter 2024 Financial ResultsAugust 8, 2024 | globenewswire.comJacobs Levy Equity Management Inc. Increases Holdings in Ikena Oncology, Inc. (NASDAQ:IKNA)Jacobs Levy Equity Management Inc. raised its holdings in shares of Ikena Oncology, Inc. (NASDAQ:IKNA - Free Report) by 813.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 513,440 shares oAugust 3, 2024 | marketbeat.comIkena Oncology, Inc. (NASDAQ:IKNA) Sees Significant Decline in Short InterestIkena Oncology, Inc. (NASDAQ:IKNA - Get Free Report) saw a significant decrease in short interest in the month of July. As of July 15th, there was short interest totalling 393,700 shares, a decrease of 70.2% from the June 30th total of 1,320,000 shares. Based on an average daily trading volume, of 318,100 shares, the days-to-cover ratio is presently 1.2 days. Approximately 1.7% of the company's stock are short sold.July 26, 2024 | marketbeat.comShort Interest in Ikena Oncology, Inc. (NASDAQ:IKNA) Decreases By 9.0%Ikena Oncology, Inc. (NASDAQ:IKNA - Get Free Report) was the recipient of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 1,410,000 shares, a decrease of 9.0% from the May 31st total of 1,550,000 shares. Approximately 6.0% of the company's stock are short sold. Based on an average daily volume of 306,200 shares, the short-interest ratio is currently 4.6 days.July 3, 2024 | marketbeat.comIkena Oncology, Inc. (NASDAQ:IKNA) Sees Significant Growth in Short InterestIkena Oncology, Inc. (NASDAQ:IKNA - Get Free Report) was the target of a significant increase in short interest in May. As of May 31st, there was short interest totalling 1,550,000 shares, an increase of 12.3% from the May 15th total of 1,380,000 shares. Based on an average trading volume of 337,100 shares, the short-interest ratio is presently 4.6 days. Currently, 6.6% of the company's stock are short sold.June 17, 2024 | marketbeat.comIkena Oncology, Inc. (NASDAQ:IKNA) Shares Bought by BVF Inc. ILBVF Inc. IL raised its stake in Ikena Oncology, Inc. (NASDAQ:IKNA - Free Report) by 50.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,769,164 shares of the company's stock after acquiring an additionalJune 13, 2024 | marketbeat.comIkena Oncology, Inc. (NASDAQ:IKNA) to Post Q2 2024 Earnings of ($0.27) Per Share, William Blair ForecastsIkena Oncology, Inc. (NASDAQ:IKNA - Free Report) - Equities researchers at William Blair lowered their Q2 2024 earnings per share estimates for Ikena Oncology in a research report issued on Wednesday, May 29th. William Blair analyst M. Phipps now forecasts that the company will earn ($0.27) per sJune 3, 2024 | marketbeat.comWedbush downgrades Ikena, cites discontinuation of lead assetMay 29, 2024 | msn.comIkena Oncology Discontinues IK-930 Program And Cuts Workforce, Analyst Calls It 'Disappointing'May 29, 2024 | msn.comThis American Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For WednesdayMay 29, 2024 | msn.comHC Wainwright Cuts Ikena Oncology (NASDAQ:IKNA) Price Target to $4.00HC Wainwright decreased their target price on shares of Ikena Oncology from $11.00 to $4.00 and set a "buy" rating for the company in a research report on Wednesday.May 29, 2024 | marketbeat.comIkena Oncology (NASDAQ:IKNA) Downgraded by WedbushWedbush downgraded shares of Ikena Oncology from an "outperform" rating to a "neutral" rating and lowered their price objective for the company from $8.00 to $2.00 in a research report on Wednesday.May 29, 2024 | marketbeat.comIkena Oncology to Cut Half of Workforce, Discontinue Development of CandidateMay 28, 2024 | marketwatch.comIkena to cut workforce by 53%, explore strategic optionsMay 28, 2024 | msn.comUPDATE – Ikena Oncology Announces Strategic UpdateMay 28, 2024 | globenewswire.comIkena Oncology Announces Strategic UpdateMay 28, 2024 | globenewswire.com Get Ikena Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for IKNA and its competitors with MarketBeat's FREE daily newsletter. Email Address IKNA Media Mentions By Week IKNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IKNA News Sentiment▼1.430.89▲Average Medical News Sentiment IKNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IKNA Articles This Week▼20▲IKNA Articles Average Week Get Ikena Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for IKNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IMMP News Today TSVT News Today INZY News Today CRDF News Today FHTX News Today AMRN News Today AARD News Today LFCR News Today ZYBT News Today ESPR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IKNA) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ikena Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ikena Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
